Fact Sheet
CNS Clinical Development in Japan
Aug 23, 2021
Download
Japan was ranked as the second largest branded pharmaceutical market and the second largest CNS market globally as well in 2020. It has the world's oldest population with almost 29% of people over the age of 65. This trend is expected to increase over the next 10-20 years making CNS drug development an important area for focus in Japan.
Contact Us